ArticleBMC cancer2016

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.

Nuria Lainez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.